More recent studies demonstrate that a selective inhibitor of HDAC3 (selective inhibitor RGFP966) suppressed striatal CAG repeat expansions and prevented cognitive defects in Huntington’s disease mice [96]. Here, HDAC3 is linked to Huntington disease.